Xiaolu Wang

发表

Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).

Adam R. Johnson, S. Bromidge, Lawren C. Wu, 2013, Bioorganic & medicinal chemistry letters.

Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.

Adam R. Johnson, Lawren C. Wu, C. Eigenbrot, 2014, Bioorganic & medicinal chemistry letters.

The synthesis and biological evaluation of sanguinarine derivatives as anti-non-small cell lung cancer agents.

Xiaoyun Lu, Ke Ding, Zhang Zhang, 2020, RSC medicinal chemistry.

Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo.

P. McEwan, J. DeVoss, A. Zarrin, 2015, Journal of medicinal chemistry.

Synthesis and immunostimulatory properties of the phosphorothioate analogues of cdiGMP.

Hongbin Yan, Wangxue Chen, R. Kuolee, 2008, Bioorganic & medicinal chemistry letters.

Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K).

Adam R. Johnson, Jianwen A. Feng, Brandon J. Bravo, 2017, Journal of medicinal chemistry.

Facile synthesis of oligonucleotide phosphoroselenoates.

Hongbin Yan, Kha Tram, Xiaolu Wang, 2007, Organic letters.

Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors.

Adam R. Johnson, P. McEwan, A. Zarrin, 2014, Journal of medicinal chemistry.

Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.

Yong Xu, Xiaoyun Lu, Zheng-chao Tu, 2020, European journal of medicinal chemistry.

Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK).

Adam R. Johnson, P. McEwan, A. Zarrin, 2014, Bioorganic & medicinal chemistry letters.

Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1).

Jianwen A. Feng, P. McEwan, R. Godemann, 2019, ACS medicinal chemistry letters.